Biotricity Statistics
Share Statistics
Biotricity has 24.39M shares outstanding. The number of shares has increased by 169.84% in one year.
| Shares Outstanding | 24.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 96.35% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 14.76M |
| Failed to Deliver (FTD) Shares | 17.37K |
| FTD / Avg. Volume | 23.67% |
Short Selling Information
The latest short interest is 459.95K, so 2.05% of the outstanding shares have been sold short.
| Short Interest | 459.95K |
| Short % of Shares Out | 2.05% |
| Short % of Float | 3.12% |
| Short Ratio (days to cover) | 5.5 |
Valuation Ratios
The PE ratio is -0.91 and the forward PE ratio is -0.7.
| PE Ratio | -0.91 |
| Forward PE | -0.7 |
| PS Ratio | 1.07 |
| Forward PS | 0.5 |
| PB Ratio | -0.43 |
| P/FCF Ratio | -1.92 |
| PEG Ratio | n/a |
Enterprise Valuation
Biotricity Inc. has an Enterprise Value (EV) of 23.00M.
| EV / Earnings | -1.63 |
| EV / Sales | 1.91 |
| EV / EBITDA | -2.59 |
| EV / EBIT | -2.61 |
| EV / FCF | -3.44 |
Financial Position
The company has a current ratio of 0.2, with a Debt / Equity ratio of -0.75.
| Current Ratio | 0.2 |
| Quick Ratio | 0.11 |
| Debt / Equity | -0.75 |
| Total Debt / Capitalization | -300.52 |
| Cash Flow / Debt | -0.3 |
| Interest Coverage | -1.7 |
Financial Efficiency
Return on equity (ROE) is 0.47% and return on capital (ROIC) is 144.77%.
| Return on Equity (ROE) | 0.47% |
| Return on Assets (ROA) | -2.37% |
| Return on Capital (ROIC) | 144.77% |
| Revenue Per Employee | 219.33K |
| Profits Per Employee | -256.26K |
| Employee Count | 55 |
| Asset Turnover | 2.03 |
| Inventory Turnover | 1.97 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -69.7% in the last 52 weeks. The beta is 1.23, so Biotricity 's price volatility has been higher than the market average.
| Beta | 1.23 |
| 52-Week Price Change | -69.7% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 44.71 |
| Average Volume (20 Days) | 73.39K |
Income Statement
In the last 12 months, Biotricity had revenue of $12.06M and earned -$14.09M in profits. Earnings per share was $-1.66.
| Revenue | 12.06M |
| Gross Profit | 8.36M |
| Operating Income | -8.83M |
| Net Income | -14.09M |
| EBITDA | -8.90M |
| EBIT | -8.83M |
| Earnings Per Share (EPS) | -1.66 |
Balance Sheet
The company has $786.06K in cash and $23.88M in debt, giving a net cash position of -$23.09M.
| Cash & Cash Equivalents | 786.06K |
| Total Debt | 23.88M |
| Net Cash | -23.09M |
| Retained Earnings | -127.50M |
| Total Assets | 5.29M |
| Working Capital | -17.42M |
Cash Flow
In the last 12 months, operating cash flow was -$6.69M and capital expenditures $0, giving a free cash flow of -$6.69M.
| Operating Cash Flow | -6.69M |
| Capital Expenditures | 0 |
| Free Cash Flow | -6.69M |
| FCF Per Share | -0.74 |
Margins
Gross margin is 69.27%, with operating and profit margins of -73.18% and -116.84%.
| Gross Margin | 69.27% |
| Operating Margin | -73.18% |
| Pretax Margin | -116.84% |
| Profit Margin | -116.84% |
| EBITDA Margin | -73.75% |
| EBIT Margin | -73.18% |
| FCF Margin | -55.49% |
Dividends & Yields
BTCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -553.33% |
| FCF Yield | -91.5% |
Analyst Forecast
Currently there are no analyst rating for BTCY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 3, 2023. It was a backward split with a ratio of 1:6.
| Last Split Date | Jul 3, 2023 |
| Split Type | backward |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | -41.51 |
| Piotroski F-Score | 4 |